Evidence map›Paper›PMID 32559195›Full record

ArticlePLoS genetics2020

NatB regulates Rb mutant cell death and tumor growth by modulating EGFR/MAPK signaling through the N-end rule pathways.

Zhentao Sheng, Wei Du

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. ZnT7 RNAi favors RafOncogene · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhentao ShengBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.
Wei DuBen May Department for Cancer Research, The University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0003-3962-370X
University of Chicago · US

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Regulation of EGFR Signaling in the Drosophila developmentR01GM120046 · NIGMS · UNIVERSITY OF CHICAGO · PI DU, WEI · 2016 to 2019
$1.3M
NIGMS NIH HHS R01 GM120046NIH HHS P40 OD018537
6 · The paper itself

Abstract

Inactivation of the Rb tumor suppressor causes context-dependent increases in cell proliferation or cell death. In a genetic screen for factors that promoted Rb mutant cell death in Drosophila, we identified Psid, a regulatory subunit of N-terminal acetyltransferase B (NatB). We showed that NatB subunits were required for elevated EGFR/MAPK signaling and Rb mutant cell survival. We showed that NatB regulates the posttranscriptional levels of the highly conserved pathway components Grb2/Drk, MAPK, and PP2AC but not that of the less conserved Sprouty. Interestingly, NatB increased the levels of positive pathway components Grb2/Drk and MAPK while decreased the levels of negative pathway component PP2AC, which were mediated by the distinct N-end rule branch E3 ubiquitin ligases Ubr4 and Cnot4, respectively. These results suggest a novel mechanism by which NatB and N-end rule pathways modulate EGFR/MAPK signaling by inversely regulating the levels of multiple conserved positive and negative pathway components. As inactivation of Psid blocked EGFR signaling-dependent tumor growth, this study raises the possibility that NatB is potentially a novel therapeutic target for cancers dependent on deregulated EGFR/Ras signaling.

Indexed as

AcetylationAcetyl Coenzyme AAllelesAnimalsAnimals, Genetically ModifiedApoptosisBlood ProteinsCell ProliferationCell SurvivalDisease Models, AnimalDrosophila ProteinsErbB ReceptorsGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMaleAcetyl Coenzyme ABlood ProteinsDrosophila ProteinsEgfr protein, DrosophilaErbB ReceptorsN-Terminal Acetyltransferase Bpsidin protein, DrosophilaRbf protein, DrosophilaReceptors, Invertebrate PeptideRetinoblastoma ProteinTranscription Factors

Identifiers

PMID32559195
PMCPMC7329143
OpenAlexW3036362570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.